drugset / Trial / NCT00136058

Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

NCT00136058

RandomizedParallel-groupOpen-label

Summary

The objective of this study is to determine if an intervention with a fracture manager to arrange bone densitometry after a hip fracture is more effective in diagnosing and treating osteoporosis when compared to "usual care". "Usual care" consists of no intervention to arrange bone mineral density (BMD) testing or therapy other than what normally occurs in the community. The investigators postulate that a fracture manager will be more effective in getting BMD done and in starting appropriate therapy.

Timeline

Start
2002-01
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule
Subject Risedronate Small molecule

Indications